Sunil Agarwal

PROFESSIONAL

Sunil Agarwal joined Sofinnova in 2016 as a Partner. He focuses on funding clinical-stage private and publicly traded biopharmaceutical companies. Dr. Agarwal has over 16 years of experience in senior executive, scientific and clinical functions. He currently serves on the Board of Directors for Myokardia and Calithera Biosciences.

Prior to joining Sofinnova, Dr. Agarwal was the Chief Medical Officer for Ultragenyx Pharmaceutical, a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases.  At Ultragenyx, Dr. Agarwal was responsible for leading clinical development and operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, pharmacology and toxicology.

Prior to Ultragenyx, Dr. Agarwal served in various leadership roles at Genentech for more than a decade.  Most recently, he held the position of Senior Vice President and Global Head of Clinical Development for OMNI (Ophthalmology, Metabolism, Neurosciences, Immunology and Infectious Diseases), and was involved in the development oversight of multiple molecules including RITUXAN®, ACTEMRA®, XOLAIR ®, LUCENTIS®, lebrikizumab, and ocrelizumab.  

Before joining Genentech, Dr. Agarwal was at MedImmune and Guilford Pharmaceuticals, where he worked in both development and medical affairs. He was Faculty at George Washington University School of Medicine as an Assistant Clinical Professor of Pediatrics.  He completed his residency at Children’s National Medical Center in Washington, D.C., and practiced in its Pediatric Emergency Department.

EDUCATION

  • BS, Cornell University
  • MD, Tufts University School of Medicine
  • Pediatric Residency Training, Children’s National Medical Center, Washington, D.C.

MEMBERSHIPS & AFFILIATIONS | AWARDS & HONORS

  • Member, Buck Advisory Council, The Buck Institute for Research on Aging
  • Member, Board of Directors, MyoKardia
  • Member, Board of Directors, Calithera Biosciences
  • Member, Advisory Board, Clinica Verde – Health & Hope (Nicaragua)
Share:
Change text size:
smaller

default

bigger